Severin Schwan’s bright, blue eyes betray no strain in spite of weeks squinting down microscopes, peering into fermentation tanks and staring at assay trays.

Since becoming chief executive of Roche in April, the 40-year-old Austrian has been on a whirlwind tour to gauge for himself what is widely viewed as the world’s most successful big pharmaceuticals company.